Pitocin
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- Pitocin
- Generic name
- OXYTOCIN
- Manufacturer
- Par Health USA, LLC
- Product type
- HUMAN PRESCRIPTION DRUG
- SPL set ID
- dddcdcc3-cd4d-4573-98ac-9468bea23a8b
- SPL ID
- d3d010b0-5caf-4f64-9ba6-1d1eeb3dc0b2
- Version
- 10
- Effective date
- 2024-08-12
- Source export date
- 2026-09-28
- Source partition
- 8
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0008-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-09-28/ae3816359e336a5de4f44607730a3d12ceb61ffa012a132189ceda22541b38ee/drug-label-0008-of-0014.json.zip
- Source manifest SHA-256
- cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
- Import run
- 20260929T050834Z
- Imported at
- 2026-09-29 05:54:59
| Harmonized routes |
|---|
| INTRAVENOUS |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| application applno | NDA | 018261 | derived:openfda.application_number |
| application number | NDA018261 | openfda.application_number | |
| brand name | Pitocin | openfda.brand_name | |
| generic name | OXYTOCIN | openfda.generic_name | |
| manufacturer name | Par Health USA, LLC | openfda.manufacturer_name | |
| ndc | package | 42023-116-83 | openfda.package_ndc |
| ndc | package | 42023-116-73 | openfda.package_ndc |
| ndc | product | 42023-116 | openfda.product_ndc |
| ndc11 | package | 42023011673 | derived:openfda.package_ndc |
| ndc11 | package | 42023011683 | derived:openfda.package_ndc |
| rxcui | 1791721 | openfda.rxcui | |
| rxcui | 207315 | openfda.rxcui | |
| rxcui | 238013 | openfda.rxcui | |
| rxcui | 1791723 | openfda.rxcui | |
| spl id | d3d010b0-5caf-4f64-9ba6-1d1eeb3dc0b2 | id | |
| spl set id | dddcdcc3-cd4d-4573-98ac-9468bea23a8b | set_id | |
| unii | 1JQS135EYN | openfda.unii |
Boxed warning cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
IMPORTANT NOTICE Elective induction of labor is defined as the initiation of labor in a pregnant individual who has no medical indications for induction. Since the available data are inadequate to evaluate the benefits-to-risks considerations, Pitocin is not indicated for elective induction of labor.
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
warnings
WARNINGS Pitocin, when given for induction of labor or augmentation of uterine activity, should be administered only by the intravenous route and with adequate medical supervision in a hospital.
Adverse reactions cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
adverse reactions
ADVERSE REACTIONS The following adverse reactions have been reported in the mother: Anaphylactic reaction Premature ventricular contractions Postpartum hemorrhage Pelvic hematoma Cardiac arrhythmia Subarachnoid hemorrhage Fatal afibrinogenemia Hypertensive episodes Nausea Rupture of the uterus Vomiting Excessive dosage or hypersensitivity to the drug may result in uterine hypertonicity, spasm, tetanic contraction, or rupture of the uterus. The possibility of increased blood loss and afibrinogenemia should be kept in mind when administering the drug. Severe water intoxication with convulsions and coma has occurred, associated with a slow oxytocin infusion over a 24-hour period. Maternal death due to oxytocin-induced water intoxication has been reported. The following adverse reactions have been reported in the fetus or neonate: Due to induced uterine motility: Due to use of oxytocin in the mother: Bradycardia Low Apgar scores at five minutes Premature ventricular contractions and other arrhythmias Neonatal jaundice Permanent CNS or brain damage Neonatal retinal hemorrhage Fetal death Neonatal seizures have been reported with the use of Pitocin. For medical advice about adverse reactions contact your medical professional. To report SUSPECTED ADVERSE REACTIONS, contact Endo at 1-800-828-9393 or FDA at 1-800-FDA-1088 (1-800-332-1088) or www.fda.gov/medwatch.
adverse reactions table
<table><col/><col/><tbody><tr><td> <paragraph>Anaphylactic reaction </paragraph></td><td> <paragraph>Premature ventricular contractions </paragraph></td></tr><tr><td> <paragraph>Postpartum hemorrhage </paragraph></td><td> <paragraph>Pelvic hematoma </paragraph></td></tr><tr><td> <paragraph>Cardiac arrhythmia </paragraph></td><td> <paragraph>Subarachnoid hemorrhage </paragraph></td></tr><tr><td> <paragraph>Fatal afibrinogenemia </paragraph></td><td> <paragraph>Hypertensive episodes </paragraph></td></tr><tr><td> <paragraph>Nausea </paragraph></td><td> <paragraph>Rupture of the uterus </paragraph></td></tr><tr><td> <paragraph>Vomiting </paragraph></td><td> </td></tr></tbody></table>
adverse reactions table
<table><col/><col/><tbody><tr><td> <paragraph>Due to induced uterine motility: </paragraph></td><td> <paragraph>Due to use of oxytocin in the mother: </paragraph></td></tr><tr><td> <paragraph> Bradycardia </paragraph></td><td> <paragraph> Low Apgar scores at five minutes </paragraph></td></tr><tr><td> <paragraph> Premature ventricular contractions and other arrhythmias </paragraph></td><td> <paragraph> Neonatal jaundice </paragraph></td></tr><tr><td> <paragraph> Permanent CNS or brain damage </paragraph></td><td> <paragraph> Neonatal retinal hemorrhage </paragraph></td></tr><tr><td> <paragraph> Fetal death </paragraph></td><td> </td></tr><tr><td> <paragraph> Neonatal seizures have been reported with the use of Pitocin. </paragraph></td><td> </td></tr></tbody></table>
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.